Skip to content

Clinical trials

Phase 2 Sarcopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcopenia Phase: Phase 2 Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20072
20091
20133
20142
20151
20162
20171
20182
20212
20222
20232
20242
20253
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting8
Not yet recruiting3
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Aging (NIA)2
Novartis Pharmaceuticals2
TNF Pharmaceuticals, Inc.2
University of Washington2
AHS Cancer Control Alberta1
Animuscure Inc.1
Aventi Biotechnology Inc.1
Axcella Health, Inc1
Biophytis1
Biruni University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcopenia34
Frailty7
Muscular Atrophy5
Obesity4
Weight Loss3
Liver Cirrhosis2
Muscle Weakness2
Osteoporosis2
Renal Insufficiency, Chronic2
Anemia, Aplastic1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.